Back to funds

Decheng Capital LLC

hedge fundUpdated 9 days ago

Managed by Decheng Capital Llc • Latest filing Q3 2026

Portfolio value
$685.1M
Q3 2026
Filings
4
Quarterly 13F history
Top-10 concentration
100.0%
Weight of largest holdings
Annualized return
—
Implied from 13F holdings

Portfolio value history

13F-disclosed portfolio value over 4 quarters

Show data table
PeriodPortfolio value
Q4 2025$743.4M
Q1 2026$661.3M
Q2 2026$731.7M
Q3 2026$685.1M

Top holdings

11 positions as of Q3 2026

View filing
C

CG ONCOLOGY INC

Value
$451.7M
Shares
6.37M
% Port
65.93%
N

Nuvation Bio Inc.

Value
$145.3M
Shares
25.95M
% Port
21.22%
A

Aclaris Therapeutics, Inc.

Value
$21.3M
Shares
4.04M
% Port
3.10%
?
4.N/A

AARDVARK THERAPEUTICS INC

Value
$20.6M
Shares
3.92M
% Port
3.01%
?
5.N/A

Upstream Bio Inc.

Value
$14.4M
Shares
2.72M
% Port
2.10%
R

Arcus Biosciences, Inc

Value
$11M
Shares
425.1K
% Port
1.60%
?
7.N/A

Equillium Inc.

Value
$7.2M
Shares
4.45M
% Port
1.05%
L

Lyell Immunopharma, Inc.

Value
$6.8M
Shares
692.0K
% Port
0.99%
?
9.N/A

Zentalis Pharmaceuticals Inc.

Value
$3.7M
Shares
1.32M
% Port
0.54%
B

BeyondSpring Inc.

Value
$2.4M
Shares
3.07M
% Port
0.34%
Q

Pyxis Oncology, Inc (formerly Apexigen)

Value
$761K
Shares
326.8K
% Port
0.11%

Explore